fluorodeoxyglucose f18 has been researched along with Ventricular Dysfunction in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| de Almeida, SA; de Brito, ASX; de Oliveira, RS; de Sousa, AS; Moll-Bernardes, RJ; Rosado-de-Castro, PH | 1 |
| Alexanderson, E; Boersma, HH; Dierckx, RA; Glauche, J; Glaudemans, AW; Juárez-Orozco, LE; Slart, RH; Tio, RA; van Veldhuisen, DJ; Zeebregts, CJ | 1 |
2 other study(ies) available for fluorodeoxyglucose f18 and Ventricular Dysfunction
| Article | Year |
|---|---|
Can PET/CT be useful in predicting ventricular arrhythmias in Chagas Disease?
Topics: Aged; Arrhythmias, Cardiac; Chagas Disease; Fibrosis; Fluorodeoxyglucose F18; Gadolinium; Humans; Inflammation; Male; Myocardium; Octreotide; Organometallic Compounds; Positron Emission Tomography Computed Tomography; Risk Assessment; Tachycardia, Ventricular; Technetium Tc 99m Sestamibi; Ventricular Dysfunction | 2020 |
Myocardial perfusion reserve in spared myocardium: correlation with infarct size and left ventricular ejection fraction.
Topics: Aged; Female; Fluorodeoxyglucose F18; Heart; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Myocardial Infarction; Myocardial Perfusion Imaging; Positron-Emission Tomography; Stroke Volume; Ventricular Dysfunction | 2013 |